Selected research
Industry Research
DNA Oligonucleotide Synthesis Service Industry Research Report 2026
Market perspective
The global DNA Oligonucleotide Synthesis Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the DNA Oligonucleotide Synthesis Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the DNA Oligonucleotide Synthesis Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the DNA Oligonucleotide Synthesis Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of DNA Oligonucleotide Synthesis Service include Genewiz, Eurofins Genomics, Gene Oracle, SBS Genetech, Creative Biolabs, Bio Basic, Kaneka Eurogentec SA, AltaBioscience and Synbio Technologies, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global DNA Oligonucleotide Synthesis Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to DNA Oligonucleotide Synthesis Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
DNA Oligonucleotide Synthesis Service Market by Company
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Creative Biolabs
Bio Basic
Kaneka Eurogentec SA
AltaBioscience
Synbio Technologies
TriLink
Azenta Life Science
KareBay Biochem
Creative Biogene
Generi Biotech
Primetech
General Biosystems
GenScript
OriGene
BBI
DNA Oligonucleotide Synthesis Service Segment by Type
Standard Oligonucleotides
Micro-Oligonucleotides
Large-scale Oligonucleotides
Degenerate Primers
Long Oligos Synthesis
DNA Oligonucleotide Synthesis Service Segment by Application
Commercial
Academic Research
DNA Oligonucleotide Synthesis Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Oligonucleotide Synthesis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DNA Oligonucleotide Synthesis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Oligonucleotide Synthesis Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of DNA Oligonucleotide Synthesis Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Standard Oligonucleotides
- Micro-Oligonucleotides
- Large-scale Oligonucleotides
- Degenerate Primers
- Long Oligos Synthesis
Applications
- Commercial
- Academic Research
Companies covered
- Genewiz
- Eurofins Genomics
- Gene Oracle
- SBS Genetech
- Creative Biolabs
- Bio Basic
- Kaneka Eurogentec SA
- AltaBioscience
- Synbio Technologies
- TriLink
- Azenta Life Science
- KareBay Biochem
- Creative Biogene
- Generi Biotech
- Primetech
- General Biosystems
- GenScript
- OriGene
- BBI
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 DNA Oligonucleotide Synthesis Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Standard Oligonucleotides
- 2.2.3 Micro-Oligonucleotides
- 2.2.4 Large-scale Oligonucleotides
- 2.2.5 Degenerate Primers
- 2.2.6 Long Oligos Synthesis
- 2.3 DNA Oligonucleotide Synthesis Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Commercial
- 2.3.3 Academic Research
- 2.4 Assumptions and Limitations
3 DNA Oligonucleotide Synthesis Service Breakdown Data by Type
- 3.1 Global DNA Oligonucleotide Synthesis Service Historic Market Size by Type (2021-2026)
- 3.2 Global DNA Oligonucleotide Synthesis Service Forecasted Market Size by Type (2027-2032)
4 DNA Oligonucleotide Synthesis Service Breakdown Data by Application
- 4.1 Global DNA Oligonucleotide Synthesis Service Historic Market Size by Application (2021-2026)
- 4.2 Global DNA Oligonucleotide Synthesis Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global DNA Oligonucleotide Synthesis Service Market Perspective (2021-2032)
- 5.2 Global DNA Oligonucleotide Synthesis Service Growth Trends by Region
- 5.2.1 Global DNA Oligonucleotide Synthesis Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 DNA Oligonucleotide Synthesis Service Historic Market Size by Region (2021-2026)
- 5.2.3 DNA Oligonucleotide Synthesis Service Forecasted Market Size by Region (2027-2032)
- 5.3 DNA Oligonucleotide Synthesis Service Market Dynamics
- 5.3.1 DNA Oligonucleotide Synthesis Service Industry Trends
- 5.3.2 DNA Oligonucleotide Synthesis Service Market Drivers
- 5.3.3 DNA Oligonucleotide Synthesis Service Market Challenges
- 5.3.4 DNA Oligonucleotide Synthesis Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top DNA Oligonucleotide Synthesis Service Players by Revenue
- 6.1.1 Global Top DNA Oligonucleotide Synthesis Service Players by Revenue (2021-2026)
- 6.1.2 Global DNA Oligonucleotide Synthesis Service Revenue Market Share by Players (2021-2026)
- 6.2 Global DNA Oligonucleotide Synthesis Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of DNA Oligonucleotide Synthesis Service Head Office and Area Served
- 6.4 Global DNA Oligonucleotide Synthesis Service Players, Product Type & Application
- 6.5 Global DNA Oligonucleotide Synthesis Service Manufacturers Established Date
- 6.6 Global DNA Oligonucleotide Synthesis Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America DNA Oligonucleotide Synthesis Service Market Size (2021-2032)
- 7.2 North America DNA Oligonucleotide Synthesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America DNA Oligonucleotide Synthesis Service Market Size by Country (2021-2026)
- 7.4 North America DNA Oligonucleotide Synthesis Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe DNA Oligonucleotide Synthesis Service Market Size (2021-2032)
- 8.2 Europe DNA Oligonucleotide Synthesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe DNA Oligonucleotide Synthesis Service Market Size by Country (2021-2026)
- 8.4 Europe DNA Oligonucleotide Synthesis Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific DNA Oligonucleotide Synthesis Service Market Size (2021-2032)
- 9.2 Asia-Pacific DNA Oligonucleotide Synthesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific DNA Oligonucleotide Synthesis Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific DNA Oligonucleotide Synthesis Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America DNA Oligonucleotide Synthesis Service Market Size (2021-2032)
- 10.2 South America DNA Oligonucleotide Synthesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America DNA Oligonucleotide Synthesis Service Market Size by Country (2021-2026)
- 10.4 South America DNA Oligonucleotide Synthesis Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa DNA Oligonucleotide Synthesis Service Market Size (2021-2032)
- 11.2 Middle East & Africa DNA Oligonucleotide Synthesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa DNA Oligonucleotide Synthesis Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa DNA Oligonucleotide Synthesis Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Genewiz
- 12.1.1 Genewiz Company Information
- 12.1.2 Genewiz Business Overview
- 12.1.3 Genewiz Revenue in DNA Oligonucleotide Synthesis Service Business (2021-2026)
- 12.1.4 Genewiz DNA Oligonucleotide Synthesis Service Product Portfolio
- 12.1.5 Genewiz Recent Developments
- 12.2 Eurofins Genomics
- 12.2.1 Eurofins Genomics Company Information
- 12.2.2 Eurofins Genomics Business Overview
- 12.2.3 Eurofins Genomics Revenue in DNA Oligonucleotide Synthesis Service Business (2021-2026)
- 12.2.4 Eurofins Genomics DNA Oligonucleotide Synthesis Service Product Portfolio
- 12.2.5 Eurofins Genomics Recent Developments
- 12.3 Gene Oracle
- 12.3.1 Gene Oracle Company Information
- 12.3.2 Gene Oracle Business Overview
- 12.3.3 Gene Oracle Revenue in DNA Oligonucleotide Synthesis Service Business (2021-2026)
- 12.3.4 Gene Oracle DNA Oligonucleotide Synthesis Service Product Portfolio
- 12.3.5 Gene Oracle Recent Developments
- 12.4 SBS Genetech
- 12.4.1 SBS Genetech Company Information
- 12.4.2 SBS Genetech Business Overview
- 12.4.3 SBS Genetech Revenue in DNA Oligonucleotide Synthesis Service Business (2021-2026)
- 12.4.4 SBS Genetech DNA Oligonucleotide Synthesis Service Product Portfolio
- 12.4.5 SBS Genetech Recent Developments
- 12.5 Creative Biolabs
- 12.5.1 Creative Biolabs Company Information
- 12.5.2 Creative Biolabs Business Overview
- 12.5.3 Creative Biolabs Revenue in DNA Oligonucleotide Synthesis Service Business (2021-2026)
- 12.5.4 Creative Biolabs DNA Oligonucleotide Synthesis Service Product Portfolio
- 12.5.5 Creative Biolabs Recent Developments
- 12.6 Bio Basic
- 12.6.1 Bio Basic Company Information
- 12.6.2 Bio Basic Business Overview
- 12.6.3 Bio Basic Revenue in DNA Oligonucleotide Synthesis Service Business (2021-2026)
- 12.6.4 Bio Basic DNA Oligonucleotide Synthesis Service Product Portfolio
- 12.6.5 Bio Basic Recent Developments
- 12.7 Kaneka Eurogentec SA
- 12.7.1 Kaneka Eurogentec SA Company Information
- 12.7.2 Kaneka Eurogentec SA Business Overview
- 12.7.3 Kaneka Eurogentec SA Revenue in DNA Oligonucleotide Synthesis Service Business (2021-2026)
- 12.7.4 Kaneka Eurogentec SA DNA Oligonucleotide Synthesis Service Product Portfolio
- 12.7.5 Kaneka Eurogentec SA Recent Developments
- 12.8 AltaBioscience
- 12.8.1 AltaBioscience Company Information
- 12.8.2 AltaBioscience Business Overview
- 12.8.3 AltaBioscience Revenue in DNA Oligonucleotide Synthesis Service Business (2021-2026)
- 12.8.4 AltaBioscience DNA Oligonucleotide Synthesis Service Product Portfolio
- 12.8.5 AltaBioscience Recent Developments
- 12.9 Synbio Technologies
- 12.9.1 Synbio Technologies Company Information
- 12.9.2 Synbio Technologies Business Overview
- 12.9.3 Synbio Technologies Revenue in DNA Oligonucleotide Synthesis Service Business (2021-2026)
- 12.9.4 Synbio Technologies DNA Oligonucleotide Synthesis Service Product Portfolio
- 12.9.5 Synbio Technologies Recent Developments
- 12.10 TriLink
- 12.10.1 TriLink Company Information
- 12.10.2 TriLink Business Overview
- 12.10.3 TriLink Revenue in DNA Oligonucleotide Synthesis Service Business (2021-2026)
- 12.10.4 TriLink DNA Oligonucleotide Synthesis Service Product Portfolio
- 12.10.5 TriLink Recent Developments
- 12.11 Azenta Life Science
- 12.11.1 Azenta Life Science Company Information
- 12.11.2 Azenta Life Science Business Overview
- 12.11.3 Azenta Life Science Revenue in DNA Oligonucleotide Synthesis Service Business (2021-2026)
- 12.11.4 Azenta Life Science DNA Oligonucleotide Synthesis Service Product Portfolio
- 12.11.5 Azenta Life Science Recent Developments
- 12.12 KareBay Biochem
- 12.12.1 KareBay Biochem Company Information
- 12.12.2 KareBay Biochem Business Overview
- 12.12.3 KareBay Biochem Revenue in DNA Oligonucleotide Synthesis Service Business (2021-2026)
- 12.12.4 KareBay Biochem DNA Oligonucleotide Synthesis Service Product Portfolio
- 12.12.5 KareBay Biochem Recent Developments
- 12.13 Creative Biogene
- 12.13.1 Creative Biogene Company Information
- 12.13.2 Creative Biogene Business Overview
- 12.13.3 Creative Biogene Revenue in DNA Oligonucleotide Synthesis Service Business (2021-2026)
- 12.13.4 Creative Biogene DNA Oligonucleotide Synthesis Service Product Portfolio
- 12.13.5 Creative Biogene Recent Developments
- 12.14 Generi Biotech
- 12.14.1 Generi Biotech Company Information
- 12.14.2 Generi Biotech Business Overview
- 12.14.3 Generi Biotech Revenue in DNA Oligonucleotide Synthesis Service Business (2021-2026)
- 12.14.4 Generi Biotech DNA Oligonucleotide Synthesis Service Product Portfolio
- 12.14.5 Generi Biotech Recent Developments
- 12.15 Primetech
- 12.15.1 Primetech Company Information
- 12.15.2 Primetech Business Overview
- 12.15.3 Primetech Revenue in DNA Oligonucleotide Synthesis Service Business (2021-2026)
- 12.15.4 Primetech DNA Oligonucleotide Synthesis Service Product Portfolio
- 12.15.5 Primetech Recent Developments
- 12.16 General Biosystems
- 12.16.1 General Biosystems Company Information
- 12.16.2 General Biosystems Business Overview
- 12.16.3 General Biosystems Revenue in DNA Oligonucleotide Synthesis Service Business (2021-2026)
- 12.16.4 General Biosystems DNA Oligonucleotide Synthesis Service Product Portfolio
- 12.16.5 General Biosystems Recent Developments
- 12.17 GenScript
- 12.17.1 GenScript Company Information
- 12.17.2 GenScript Business Overview
- 12.17.3 GenScript Revenue in DNA Oligonucleotide Synthesis Service Business (2021-2026)
- 12.17.4 GenScript DNA Oligonucleotide Synthesis Service Product Portfolio
- 12.17.5 GenScript Recent Developments
- 12.18 OriGene
- 12.18.1 OriGene Company Information
- 12.18.2 OriGene Business Overview
- 12.18.3 OriGene Revenue in DNA Oligonucleotide Synthesis Service Business (2021-2026)
- 12.18.4 OriGene DNA Oligonucleotide Synthesis Service Product Portfolio
- 12.18.5 OriGene Recent Developments
- 12.19 BBI
- 12.19.1 BBI Company Information
- 12.19.2 BBI Business Overview
- 12.19.3 BBI Revenue in DNA Oligonucleotide Synthesis Service Business (2021-2026)
- 12.19.4 BBI DNA Oligonucleotide Synthesis Service Product Portfolio
- 12.19.5 BBI Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst